Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Max Wohlauer

Concepts (380)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vascular Surgical Procedures
18
2024
294
3.950
 Why?
Endovascular Procedures
9
2024
302
1.860
 Why?
Peripheral Arterial Disease
5
2025
456
1.320
 Why?
Surgeons
7
2024
259
1.250
 Why?
Blood Coagulation Disorders
10
2016
167
1.230
 Why?
Blood Vessel Prosthesis Implantation
6
2022
198
1.110
 Why?
Shock, Hemorrhagic
10
2024
165
1.080
 Why?
Thrombelastography
13
2020
150
1.060
 Why?
Acute Lung Injury
8
2015
264
1.040
 Why?
Vascular System Injuries
3
2023
72
1.010
 Why?
Elective Surgical Procedures
3
2024
163
0.970
 Why?
Aortic Aneurysm, Abdominal
4
2022
132
0.940
 Why?
Wounds and Injuries
13
2016
707
0.930
 Why?
Leg Injuries
1
2023
28
0.820
 Why?
Diabetic Foot
1
2022
25
0.810
 Why?
Intermittent Claudication
2
2022
118
0.810
 Why?
Burnout, Professional
4
2021
407
0.800
 Why?
Blood Transfusion
8
2016
295
0.750
 Why?
Pneumonia, Viral
3
2020
337
0.720
 Why?
Coronavirus Infections
3
2020
333
0.720
 Why?
Mental Health
3
2022
683
0.710
 Why?
Cultural Diversity
1
2021
62
0.700
 Why?
Sexism
1
2021
55
0.700
 Why?
Ergonomics
1
2020
23
0.700
 Why?
Musculoskeletal Pain
1
2020
34
0.680
 Why?
Aortic Aneurysm, Thoracic
3
2017
127
0.670
 Why?
Internship and Residency
4
2020
1045
0.670
 Why?
Multiple Organ Failure
4
2013
122
0.650
 Why?
Aggression
1
2021
195
0.640
 Why?
Muscle Fatigue
1
2020
101
0.640
 Why?
Pandemics
8
2023
1477
0.640
 Why?
Foot
1
2020
93
0.630
 Why?
Continuity of Patient Care
2
2012
275
0.630
 Why?
Tendons
1
2020
106
0.620
 Why?
Betacoronavirus
3
2020
247
0.620
 Why?
Racism
1
2021
129
0.620
 Why?
Occupational Diseases
1
2020
138
0.610
 Why?
Axillary Artery
2
2015
12
0.610
 Why?
Lymph
3
2015
32
0.590
 Why?
Running
1
2020
222
0.570
 Why?
Attitude of Health Personnel
3
2024
1090
0.560
 Why?
Serum Albumin, Human
1
2017
5
0.560
 Why?
Vascular Diseases
1
2020
232
0.560
 Why?
Hypoalbuminemia
1
2017
30
0.550
 Why?
Curriculum
3
2019
910
0.520
 Why?
Research Design
1
2022
1036
0.520
 Why?
Blood Platelet Disorders
2
2013
10
0.500
 Why?
Ischemia
6
2025
394
0.490
 Why?
Axilla
1
2015
45
0.490
 Why?
Aneurysm, False
1
2015
48
0.480
 Why?
Osteosarcoma
1
2015
72
0.460
 Why?
Diabetes Mellitus
1
2022
996
0.450
 Why?
Soft Tissue Neoplasms
1
2015
112
0.450
 Why?
Humans
64
2025
128499
0.440
 Why?
Bone Neoplasms
1
2015
231
0.410
 Why?
Health Knowledge, Attitudes, Practice
1
2021
1276
0.410
 Why?
Matrix Metalloproteinase 13
1
2012
23
0.400
 Why?
Neutrophils
4
2015
1192
0.400
 Why?
Physicians
1
2021
863
0.400
 Why?
Patient Handoff
1
2012
31
0.400
 Why?
Saline Solution, Hypertonic
1
2012
38
0.400
 Why?
Duodenal Neoplasms
1
2012
21
0.400
 Why?
Common Bile Duct Neoplasms
1
2012
27
0.390
 Why?
Carcinoma, Papillary
1
2013
76
0.390
 Why?
Ampulla of Vater
1
2012
38
0.390
 Why?
Intestinal Volvulus
1
2012
13
0.390
 Why?
Personnel Staffing and Scheduling
1
2012
88
0.390
 Why?
Colonic Diseases
1
2012
32
0.390
 Why?
Pancreatic Ducts
1
2013
79
0.390
 Why?
Neoplasms, Multiple Primary
1
2012
54
0.390
 Why?
Blood Coagulation
5
2021
236
0.390
 Why?
Treatment Outcome
18
2025
10162
0.380
 Why?
Hemodilution
1
2011
9
0.370
 Why?
Multiple Trauma
1
2012
101
0.370
 Why?
Wounds, Penetrating
1
2012
63
0.360
 Why?
General Surgery
1
2012
152
0.360
 Why?
Male
41
2025
63045
0.360
 Why?
Patient Care Management
1
2011
56
0.350
 Why?
Rats, Sprague-Dawley
9
2015
2272
0.350
 Why?
Time-to-Treatment
2
2024
180
0.350
 Why?
Wounds, Nonpenetrating
2
2015
272
0.330
 Why?
Female
38
2025
68268
0.330
 Why?
Patient Transfer
1
2012
162
0.330
 Why?
Carcinoma, Pancreatic Ductal
1
2013
268
0.330
 Why?
Delivery of Health Care, Integrated
2
2024
240
0.330
 Why?
Mesentery
4
2015
47
0.320
 Why?
Resuscitation
3
2024
234
0.320
 Why?
Risk Assessment
9
2021
3232
0.300
 Why?
Platelet Aggregation Inhibitors
5
2022
439
0.290
 Why?
Time Factors
9
2025
6506
0.280
 Why?
Thrombophilia
2
2021
80
0.280
 Why?
Risk Factors
10
2025
9737
0.280
 Why?
Computer Simulation
1
2011
939
0.270
 Why?
Anticoagulants
4
2021
634
0.260
 Why?
Rats
8
2014
5246
0.260
 Why?
Aged
12
2025
21976
0.260
 Why?
Software
1
2011
608
0.260
 Why?
Blood Platelets
4
2014
377
0.260
 Why?
Fibrinolysis
3
2020
137
0.250
 Why?
Education, Medical, Graduate
2
2021
435
0.250
 Why?
Middle Aged
22
2025
30923
0.250
 Why?
Adaptation, Psychological
2
2021
617
0.250
 Why?
Prospective Studies
9
2022
7069
0.250
 Why?
Adenocarcinoma
1
2012
894
0.240
 Why?
Balloon Occlusion
2
2024
34
0.240
 Why?
Retrospective Studies
9
2025
14472
0.240
 Why?
Diagnosis, Differential
3
2015
1412
0.240
 Why?
Pancreatic Neoplasms
1
2013
878
0.240
 Why?
Hospitals, Public
1
2025
26
0.240
 Why?
Adult
25
2024
35302
0.240
 Why?
Lower Extremity
3
2023
403
0.230
 Why?
Angiography
2
2023
192
0.230
 Why?
Kidney
1
2012
1310
0.230
 Why?
Health Surveys
3
2021
493
0.230
 Why?
Varicose Veins
1
2024
17
0.220
 Why?
Venous Thromboembolism
2
2021
283
0.220
 Why?
Patient Care Team
2
2024
598
0.220
 Why?
Brain Injuries
3
2014
465
0.220
 Why?
Injury Severity Score
7
2016
509
0.220
 Why?
Occupational Health
3
2021
192
0.220
 Why?
Heparin, Low-Molecular-Weight
2
2014
29
0.210
 Why?
Endarterectomy, Carotid
1
2023
47
0.210
 Why?
Physician-Patient Relations
2
2021
530
0.200
 Why?
Hospital Mortality
2
2021
847
0.200
 Why?
Arachidonic Acid
2
2014
114
0.200
 Why?
Ischemic Attack, Transient
1
2023
60
0.200
 Why?
Acute Disease
5
2025
965
0.200
 Why?
Specialties, Surgical
2
2020
73
0.200
 Why?
Carotid Stenosis
1
2023
85
0.200
 Why?
Prevalence
3
2020
2553
0.200
 Why?
Blood Coagulation Tests
2
2020
60
0.200
 Why?
United States
10
2024
13840
0.200
 Why?
Observational Studies as Topic
1
2022
108
0.190
 Why?
Pulmonary Embolism
1
2024
209
0.190
 Why?
Iliac Aneurysm
1
2022
19
0.190
 Why?
Arterial Occlusive Diseases
1
2022
80
0.190
 Why?
Point-of-Care Systems
3
2012
146
0.190
 Why?
Peripheral Vascular Diseases
1
2022
102
0.190
 Why?
Aorta
1
2024
408
0.180
 Why?
Arteriovenous Fistula
1
2021
35
0.180
 Why?
Aortic Rupture
1
2021
25
0.180
 Why?
Iliac Vein
1
2021
12
0.180
 Why?
Work Capacity Evaluation
1
2020
11
0.180
 Why?
Culturally Competent Care
1
2021
57
0.180
 Why?
Catheters
1
2021
66
0.170
 Why?
Vena Cava, Inferior
1
2021
68
0.170
 Why?
Physicians, Women
1
2021
70
0.170
 Why?
Tenotomy
1
2020
13
0.170
 Why?
Iatrogenic Disease
1
2020
54
0.170
 Why?
Tendon Transfer
1
2020
24
0.170
 Why?
Catheterization, Peripheral
1
2021
104
0.160
 Why?
International Cooperation
1
2020
173
0.160
 Why?
Decompression, Surgical
1
2020
99
0.160
 Why?
Societies, Medical
2
2020
744
0.160
 Why?
Workload
3
2021
151
0.160
 Why?
Posture
1
2020
176
0.160
 Why?
Thromboembolism
1
2020
111
0.160
 Why?
Infection Control
1
2020
138
0.160
 Why?
Partnership Practice
1
2018
3
0.160
 Why?
Mentors
1
2021
178
0.160
 Why?
Insurance Benefits
1
2018
12
0.160
 Why?
Catheterization, Central Venous
1
2020
103
0.150
 Why?
Venous Thrombosis
1
2021
176
0.150
 Why?
Physical Endurance
1
2020
262
0.150
 Why?
Health Services Needs and Demand
1
2020
262
0.150
 Why?
Surveys and Questionnaires
7
2022
5371
0.150
 Why?
Pain Measurement
1
2020
488
0.150
 Why?
Medically Uninsured
1
2018
127
0.140
 Why?
Triage
1
2020
205
0.140
 Why?
Walking
1
2022
500
0.140
 Why?
Registries
2
2024
1883
0.140
 Why?
Insurance Coverage
1
2018
219
0.140
 Why?
Statistics, Nonparametric
3
2014
419
0.140
 Why?
Biomechanical Phenomena
1
2020
766
0.130
 Why?
Nutrition Assessment
1
2017
85
0.130
 Why?
Purinergic P2Y Receptor Antagonists
2
2014
66
0.130
 Why?
Insurance, Health
1
2018
267
0.130
 Why?
Chronic Disease
3
2024
1692
0.130
 Why?
Aged, 80 and over
5
2025
7057
0.130
 Why?
Recovery of Function
1
2020
633
0.130
 Why?
Hemostatic Techniques
1
2016
45
0.120
 Why?
Practice Patterns, Physicians'
2
2024
1262
0.120
 Why?
Receptor, PAR-2
1
2015
6
0.120
 Why?
Phosphopyruvate Hydratase
1
2015
26
0.120
 Why?
Exsanguination
2
2012
19
0.120
 Why?
Practice Guidelines as Topic
2
2021
1490
0.120
 Why?
Motor Activity
1
2020
669
0.120
 Why?
Sex Factors
1
2021
1951
0.120
 Why?
Cohort Studies
3
2022
5402
0.120
 Why?
Plasminogen
1
2015
31
0.120
 Why?
Myocardial Infarction
1
2022
1015
0.120
 Why?
Geriatric Assessment
1
2017
205
0.120
 Why?
Microcirculation
1
2015
137
0.120
 Why?
Biomedical Research
1
2021
633
0.120
 Why?
Systemic Inflammatory Response Syndrome
1
2015
85
0.120
 Why?
Stroke
1
2023
1073
0.120
 Why?
Kaplan-Meier Estimate
1
2017
856
0.120
 Why?
Down-Regulation
1
2017
632
0.110
 Why?
Animals
10
2015
34647
0.110
 Why?
Medicaid
1
2018
433
0.110
 Why?
Thrombin
2
2015
144
0.110
 Why?
Blood Vessel Prosthesis
3
2022
124
0.110
 Why?
Odds Ratio
1
2017
1019
0.110
 Why?
Frailty
1
2017
153
0.110
 Why?
Proportional Hazards Models
1
2017
1200
0.110
 Why?
Chi-Square Distribution
2
2012
512
0.110
 Why?
Limb Salvage
2
2025
57
0.110
 Why?
Prosthesis Design
3
2022
304
0.100
 Why?
Medicare
1
2018
719
0.100
 Why?
Subclavian Artery
1
2013
28
0.100
 Why?
Carotid Artery, Common
1
2013
35
0.100
 Why?
Postoperative Complications
2
2021
2462
0.100
 Why?
Fibrinogen
1
2014
164
0.100
 Why?
Bronchoalveolar Lavage Fluid
2
2012
624
0.100
 Why?
History, 17th Century
1
2012
14
0.100
 Why?
Comorbidity
2
2021
1541
0.100
 Why?
History, 18th Century
1
2012
18
0.100
 Why?
Isoflurane
1
2012
8
0.100
 Why?
Brazil
2
2025
154
0.100
 Why?
Anesthetics, Inhalation
1
2012
16
0.100
 Why?
History, 19th Century
1
2012
57
0.100
 Why?
Sigmoid Diseases
1
2012
10
0.100
 Why?
Muscle, Skeletal
1
2022
1624
0.100
 Why?
Social Responsibility
1
2012
47
0.100
 Why?
Colorado
5
2016
4399
0.100
 Why?
Arachidonate 5-Lipoxygenase
1
2012
38
0.100
 Why?
Neutrophil Infiltration
1
2012
103
0.100
 Why?
Nebulizers and Vaporizers
1
2012
81
0.100
 Why?
Stress, Psychological
1
2020
1064
0.100
 Why?
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
1
2011
3
0.100
 Why?
Biopsy, Needle
1
2012
187
0.100
 Why?
Narration
1
2012
57
0.100
 Why?
Blood Transfusion, Autologous
1
2011
16
0.100
 Why?
Trauma Severity Indices
1
2012
104
0.100
 Why?
Hydroxyeicosatetraenoic Acids
1
2011
39
0.090
 Why?
Proteomics
3
2015
1018
0.090
 Why?
Efficiency, Organizational
1
2012
133
0.090
 Why?
Social Values
1
2012
34
0.090
 Why?
Depression
1
2020
1292
0.090
 Why?
Multivariate Analysis
2
2013
1499
0.090
 Why?
Random Allocation
1
2012
344
0.090
 Why?
Colectomy
1
2012
94
0.090
 Why?
Renal Replacement Therapy
1
2012
87
0.090
 Why?
Survival Rate
2
2016
1871
0.090
 Why?
Kidney Function Tests
1
2012
145
0.090
 Why?
Extravascular Lung Water
1
2011
7
0.090
 Why?
History, 20th Century
1
2012
288
0.090
 Why?
Oxidative Stress
3
2014
1191
0.090
 Why?
Disseminated Intravascular Coagulation
1
2011
34
0.090
 Why?
Docosahexaenoic Acids
1
2011
83
0.090
 Why?
Hypothermia
1
2011
34
0.090
 Why?
Abdominal Pain
1
2012
144
0.090
 Why?
Abdominal Injuries
1
2012
117
0.090
 Why?
Administration, Inhalation
1
2012
661
0.090
 Why?
Efficiency
1
2011
91
0.090
 Why?
Aorta, Thoracic
1
2013
260
0.090
 Why?
Quality Assurance, Health Care
1
2012
316
0.090
 Why?
Health Care Surveys
2
2024
558
0.090
 Why?
Pancreatectomy
1
2013
241
0.090
 Why?
Superoxides
1
2011
198
0.090
 Why?
Proteome
1
2014
432
0.090
 Why?
Trauma Centers
4
2016
401
0.090
 Why?
Acidosis
1
2011
88
0.080
 Why?
Interprofessional Relations
1
2012
270
0.080
 Why?
Biomarkers
3
2017
3893
0.080
 Why?
Endothelial Cells
1
2015
703
0.080
 Why?
Logistic Models
2
2012
1980
0.080
 Why?
Cross-Sectional Studies
4
2020
5045
0.080
 Why?
Models, Animal
1
2011
367
0.080
 Why?
Thrombosis
1
2013
343
0.080
 Why?
Quality Improvement
2
2021
1097
0.080
 Why?
Safety
1
2011
328
0.080
 Why?
Recurrence
1
2012
1004
0.080
 Why?
Reperfusion Injury
1
2011
264
0.080
 Why?
Lymph Nodes
1
2011
466
0.070
 Why?
Disease Models, Animal
3
2014
3947
0.070
 Why?
Immunohistochemistry
1
2012
1668
0.070
 Why?
Tissue and Organ Procurement
1
2012
288
0.070
 Why?
Adolescent
5
2020
20304
0.070
 Why?
Sensitivity and Specificity
1
2012
1817
0.070
 Why?
Lung
3
2015
3748
0.070
 Why?
Prognosis
2
2013
3780
0.070
 Why?
Evidence-Based Medicine
1
2011
712
0.070
 Why?
Chromatography, Liquid
3
2014
381
0.070
 Why?
Communication
1
2012
841
0.060
 Why?
Tandem Mass Spectrometry
3
2014
456
0.060
 Why?
Incidence
1
2012
2638
0.060
 Why?
Embolectomy
1
2025
13
0.060
 Why?
Clinical Competence
1
2012
1009
0.060
 Why?
Databases, Factual
2
2021
1267
0.060
 Why?
Electronic Health Records
1
2012
974
0.060
 Why?
Platelet Function Tests
2
2014
25
0.050
 Why?
Aortography
2
2013
51
0.050
 Why?
Reproducibility of Results
1
2011
3021
0.050
 Why?
Interdisciplinary Communication
1
2024
185
0.050
 Why?
Receptors, Purinergic P2
2
2013
22
0.050
 Why?
Platelet Activation
2
2014
89
0.050
 Why?
Mesenteric Artery, Inferior
1
2022
2
0.050
 Why?
Off-Label Use
1
2022
51
0.050
 Why?
Carotid Arteries
1
2023
194
0.050
 Why?
Iliac Artery
1
2022
54
0.050
 Why?
Cooperative Behavior
1
2024
424
0.050
 Why?
Product Labeling
1
2021
6
0.050
 Why?
Tomography, X-Ray Computed
3
2018
2517
0.050
 Why?
Blood Component Transfusion
2
2012
82
0.050
 Why?
Mitochondrial Proteins
2
2015
245
0.050
 Why?
Phlebography
1
2021
38
0.050
 Why?
Depersonalization
1
2020
7
0.040
 Why?
Protective Factors
1
2021
91
0.040
 Why?
Work-Life Balance
1
2020
18
0.040
 Why?
Fibrin Clot Lysis Time
1
2020
9
0.040
 Why?
Rivaroxaban
1
2022
252
0.040
 Why?
Personal Protective Equipment
1
2020
50
0.040
 Why?
Partial Thromboplastin Time
1
2020
52
0.040
 Why?
Heparin
1
2021
253
0.040
 Why?
Fibrin Fibrinogen Degradation Products
1
2020
83
0.040
 Why?
Young Adult
5
2014
12349
0.040
 Why?
Aspirin
1
2022
378
0.040
 Why?
Dose-Response Relationship, Drug
2
2014
1951
0.040
 Why?
Psychiatric Status Rating Scales
1
2020
521
0.040
 Why?
Popliteal Artery
1
2018
58
0.040
 Why?
Clinical Decision-Making
1
2021
302
0.040
 Why?
Hemorrhage
1
2022
666
0.040
 Why?
Patient Protection and Affordable Care Act
1
2018
100
0.040
 Why?
Stents
1
2022
504
0.040
 Why?
Global Health
1
2020
330
0.040
 Why?
Military Personnel
1
2024
514
0.040
 Why?
Pilot Projects
1
2022
1568
0.030
 Why?
Host-Pathogen Interactions
1
2020
349
0.030
 Why?
Career Choice
1
2019
207
0.030
 Why?
Guideline Adherence
1
2021
524
0.030
 Why?
Clinical Trials as Topic
1
2021
1003
0.030
 Why?
Renal Dialysis
1
2020
423
0.030
 Why?
Alarmins
1
2015
24
0.030
 Why?
Emotions
1
2020
535
0.030
 Why?
Bacterial Translocation
1
2015
40
0.030
 Why?
Case-Control Studies
2
2014
3339
0.030
 Why?
Intensive Care Units
1
2020
735
0.030
 Why?
Intercellular Adhesion Molecule-1
1
2015
133
0.030
 Why?
Tranexamic Acid
1
2015
36
0.030
 Why?
Pain
1
2020
751
0.030
 Why?
Inflammation
2
2015
2666
0.030
 Why?
Mesenteric Artery, Superior
1
2013
15
0.030
 Why?
Renal Artery
1
2013
33
0.030
 Why?
Extracellular Matrix Proteins
1
2014
140
0.030
 Why?
Glasgow Coma Scale
1
2014
167
0.030
 Why?
Age Factors
1
2020
3122
0.030
 Why?
Cluster Analysis
1
2014
479
0.030
 Why?
Platelet Count
1
2013
82
0.030
 Why?
Blood Proteins
1
2014
240
0.030
 Why?
Receptors, Purinergic P2Y12
1
2012
6
0.030
 Why?
Leukotriene C4
1
2012
11
0.020
 Why?
Anastomosis, Surgical
1
2013
149
0.020
 Why?
Leukotriene B4
1
2012
40
0.020
 Why?
Reference Values
1
2014
780
0.020
 Why?
Lipoxygenase Inhibitors
1
2012
35
0.020
 Why?
Ticlopidine
1
2012
54
0.020
 Why?
Eicosanoids
1
2012
55
0.020
 Why?
Peroxidase
1
2012
169
0.020
 Why?
Cell Membrane
1
2015
725
0.020
 Why?
Fluorescent Antibody Technique
1
2012
370
0.020
 Why?
Dinoprostone
1
2012
187
0.020
 Why?
Flow Cytometry
1
2015
1142
0.020
 Why?
Health Services Accessibility
1
2018
901
0.020
 Why?
Mass Spectrometry
1
2014
663
0.020
 Why?
Cerebrovascular Circulation
1
2013
217
0.020
 Why?
Acute-Phase Proteins
1
2011
67
0.020
 Why?
Oxidation-Reduction
1
2014
1003
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2011
328
0.020
 Why?
Quality of Life
1
2022
2688
0.020
 Why?
Waiting Lists
1
2012
237
0.020
 Why?
Hemolysis
1
2011
199
0.020
 Why?
Indoles
1
2012
372
0.020
 Why?
Membrane Glycoproteins
1
2011
468
0.020
 Why?
Mice, Transgenic
1
2012
2069
0.020
 Why?
Carrier Proteins
1
2011
732
0.020
 Why?
Follow-Up Studies
1
2013
4874
0.010
 Why?
Cells, Cultured
1
2011
4017
0.010
 Why?
Mice, Inbred C57BL
1
2012
5281
0.010
 Why?
Mice
1
2012
16620
0.010
 Why?
Wohlauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (380) concept(s)
_
Co-Authors Expand Description
See all (35) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)